MLchartDataset catalogue

viral vector-based cancer vaccine VAC85135

Term · Oncology and biomedicine · MLC-T-ONC-017512

An off-the-shelf (OTS) cancer vaccine consisting of a viral vector encoding certain neoantigens, with potential immunomodulating and antineoplastic activities. Upon administration of the viral vector-based cancer vaccine VAC85135, the expressed neoantigens elicit a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing these neoantigens.

Table 1. Record
IdentifierMLC-T-ONC-017512
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017512",
  "term": "viral vector-based cancer vaccine VAC85135",
  "field": "Oncology and biomedicine",
  "definition": "An off-the-shelf (OTS) cancer vaccine consisting of a viral vector encoding certain neoantigens, with potential immunomodulating and antineoplastic activities. Upon administration of the viral vector-based cancer vaccine VAC85135, the expressed neoantigens elicit a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing these neoantigens.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/viral-vector-based-cancer-vaccine-vac85135/"
}

Record 17,259 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.